A real-world one year study to assess impact of early initiation of paliperidone palmitate on the maintenance of functionality in patients with newly diagnosed schizophrenia
Latest Information Update: 08 Oct 2020
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Acronyms TIME Study
- 08 Oct 2020 New trial record
- 15 Sep 2020 Interim results (n=78) presented at the 33rd Annual Congress of the European College of Neuropsychopharmacology